Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intestinal Microbiome Profiles in Women With Gynecological Tumors and Pelvic Toxicity Secondary to Radiotherapy and Chemotherapy: Comparison With Controls and Effect of Rectal Ozone Treatment.

NCT07259681 is registered in ClinicalTrials.gov with Bernardino Clavo, MD, PhD as lead sponsor.

NCT NCT07259681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07259681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intestinal Microbiome Profiles in Women With Gynecological Tumors and Pelvic Toxicity Secondary to Radiotherapy and Chemotherapy: Comparison With Controls and Effect of Rectal Ozone Treatment.
Lead sponsor
Bernardino Clavo, MD, PhD
Phase
Observational
Overall status
Recruiting
Start date
January 15, 2026
Completion date
March 31, 2028
Enrollment
38 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy toxicity, dysbiosis, gynecological tumors, pelvic toxicity, quality of life, radiation cystitis, radiation proctitis, radiation toxicity, vaginal mucositis, vulvar mucositis